Lung Transplant Insurance Claim Denied? How to Appeal

A lung transplant denial is among the most consequential insurance decisions a patient can face. For patients with end-stage lung disease — whether from COPD, pulmonary fibrosis, cystic fibrosis, or other conditions — a transplant may represent the only viable path to survival. If your insurer has denied coverage for a lung transplant evaluation, listing, or the transplant itself, you have the right to appeal, and the clinical evidence supporting transplantation in appropriate candidates is substantial.

Why Insurers Deny Lung Transplant Claims

Not Medically Necessary Determinations

Insurers may deny lung transplant coverage by arguing the patient does not meet clinical necessity criteria. This most often occurs when the insurer's medical reviewers apply overly restrictive criteria not consistent with the International Society for Heart and Lung Transplantation (ISHLT) guidelines, or when documentation of disease severity is incomplete.

The ISHLT has published consensus documents on the selection of candidates for lung transplantation, describing criteria for referral and listing across a range of underlying diagnoses. These guidelines outline thresholds for disease severity — including pulmonary function metrics, exercise capacity, and expected survival benefit — that support transplant candidacy.

Center of Excellence Network Restrictions

Many commercial insurers require that lung transplants be performed at a designated Center of Excellence (COE). A denial may arise if the recommended transplant center is not in the insurer's COE network, or if the insurer disputes whether the center meets its quality benchmarks. If you have been referred to a specific transplant center based on your physician's clinical recommendation, your appeal should address why that center is the appropriate choice for your case, and whether any in-network alternatives are clinically equivalent.

Exclusions for Specific Diagnoses or Comorbidities

Insurers may attempt to exclude certain underlying diagnoses from transplant coverage, or deny based on comorbidities they classify as contraindications. Common disputed contraindications include age-related limitations, prior malignancy, BMI thresholds, or certain psychosocial factors. Your appeal should address these issues directly, referencing ISHLT guidance on absolute versus relative contraindications.

Retransplantation Denials

If you previously received a lung transplant and require retransplantation due to chronic lung allograft dysfunction (CLAD) or primary graft dysfunction, expect heightened scrutiny. Insurers may deny retransplantation as not medically necessary or cite survival data concerns. Your transplant team's documentation should address the evidence base for retransplantation in your specific situation.

Pre-Transplant Evaluation and Testing Denials

Before listing, patients undergo extensive evaluation — pulmonary function tests, cardiac assessment, CT imaging, bronchoscopy, right heart catheterization, and psychosocial evaluation. Insurers may deny individual components of this evaluation as not medically necessary. These denials should be appealed individually, as each element serves a defined clinical purpose in determining candidacy.

How to Build a Winning Lung Transplant Appeal

Establish Disease Severity with Objective Metrics

Lung transplant appeals require comprehensive documentation of end-stage disease. Gather:

• Pulmonary function tests: FEV1, FVC, FEV1/FVC ratio, DLCO (diffusion capacity)
• Six-minute walk test (6MWT) distance and oxygen requirements
• Arterial blood gas results documenting hypoxemia and/or hypercapnia
• Echocardiogram and right heart catheterization results (pulmonary hypertension evaluation)
• CT chest imaging showing extent of structural lung disease
• Hospitalization records for acute exacerbations or respiratory failure
• Documentation of oxygen dependency and daily oxygen requirements

Reference ISHLT Transplant Listing Criteria

The ISHLT consensus document on the selection of lung transplant candidates provides diagnosis-specific listing criteria. For example:

• COPD/emphysema: BODE index of 7–10, FEV1 below 20% predicted, or significant functional decline
• IPF/pulmonary fibrosis: DLCO below 39% predicted, significant decline in FVC over 6 months, SpO2 below 88% on 6MWT, or honeycombing on CT
• Cystic fibrosis: FEV1 below 30% predicted, rapid decline, or 6MWT distance below 400 meters
• Pulmonary arterial hypertension: WHO functional class III–IV despite maximal therapy, rapidly progressive disease

Your physician's letter should map your clinical data to these criteria explicitly.

Reference UNOS and the Lung Allocation Score

UNOS (United Network for Organ Sharing) administers the national organ transplant system. Patients are ranked by Lung Allocation Score (LAS), which is calculated from clinical data and predicts both urgency of need and likelihood of post-transplant benefit. A high LAS is powerful supporting evidence in an appeal.

Obtain Transplant Team Documentation

The transplant center's multidisciplinary team — including pulmonologists, cardiothoracic surgeons, transplant coordinators, and social workers — should document their evaluation findings and their determination that you are an appropriate transplant candidate. This institutional assessment carries significant weight in an appeal.

Address Contraindications Directly

If the denial references comorbidities as contraindications, your appeal should address each one. Distinguish between absolute contraindications (which genuinely preclude transplant under current ISHLT guidance) and relative contraindications (which require individualized assessment). Many conditions that were once considered absolute contraindications are now managed with individualized risk assessment at experienced centers.

Know Your Timeline — Appeals Must Be Urgent

For a patient with end-stage lung disease, delays caused by insurance denials can be life-threatening. Insurers are required to provide expedited review for urgent medical situations — typically within 72 hours for urgent Prior Authorization Denied: How to Appeal" class="auto-link">prior authorization

• Organ Transplant Insurance Denied? How to Appeal Your Claim

Related Reading

• Bone Marrow Transplant Insurance Claim Denied? How to Appeal
• Corneal Transplant Insurance Denied? How to Appeal
• Kidney Transplant Insurance Claim Denied? How to Appeal
• Lung Cancer Treatment Insurance Denied? How to Appeal
• Organ Transplant Insurance Denied? How to Appeal Your Claim